ANDA 75944, held by Sun Pharm Inds Ltd. Lisinopril.
As of Nov 14, 2026, ANDA 75944 (Lisinopril), held by Sun Pharm Inds Ltd, was first approved by FDA on Jul 1, 2002, with 16 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jul 1, 2002 | Original application | Approved |
| Lisinopril2.5MG · tablet;oral | Lisinopril | Rx |
| Lisinopril5MG · tablet;oral | Lisinopril | Rx |
| Lisinopril10MG · tablet;oral | Lisinopril | Rx |
| Lisinopril20MG · tablet;oral | Lisinopril | Rx |
| Lisinopril40MG · tablet;oral | Lisinopril | Rx |
| Lisinopril30MG · tablet;oral | Lisinopril | Rx |
| Apr 27, 2020 | Supplement 29Labeling · Standard review | Approved | None posted |
| Sep 16, 2016 | Supplement 28Labeling · Standard review | Approved | None posted |
| Nov 25, 2015 | Supplement 27Labeling · Standard review | Approved | None posted |
| Aug 25, 2015 | Supplement 24Labeling · Standard review | Approved | None posted |
| Aug 25, 2015 | Supplement 25Labeling · Standard review | Approved | None posted |
| Aug 25, 2015 | Supplement 26Labeling · Standard review | Approved | None posted |
| Aug 5, 2013 | Supplement 20Labeling · Standard review | Approved | None posted |
| Aug 5, 2013 | Supplement 21Labeling · Standard review | Approved | None posted |
| Aug 5, 2013 | Supplement 22Labeling · Standard review | Approved | None posted |
| Aug 5, 2013 | Supplement 23Labeling · Standard review | Approved | None posted |
| Mar 12, 2010 | Supplement 19Labeling | Approved | None posted |
| Mar 8, 2010 | Supplement 18Labeling | Approved | None posted |
| Feb 22, 2010 | Supplement 17Labeling | Approved | None posted |
| Sep 24, 2007 | Supplement 12Labeling | Approved | None posted |
| Feb 11, 2003 | Supplement 1Manufacturing | Approved | None posted |
| Feb 11, 2003 | Supplement 2Labeling | Approved | None posted |
| Jul 1, 2002 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters